Skip to main content
Fig. 4. | Cardiovascular Diabetology

Fig. 4.

From: Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study

Fig. 4.

3P-MACE by baseline CVD history. The forest plot shows hazard ratios (HR) and 95% confidence intervals (CI) of all study endpoints in patients stratified within each group by presence or absence of CVD at baseline. The numbers of events in each subgroup and the corresponding rate (between brackets, in events/1000 person-years) are reported. In addition to p values of the HR in each subgroup, the interaction term (group × CVD) p value (p int.) is also reported. Subject distribution was as follows: 591 GLP-1RA initiators with CVD vs. 3472 without; 632 basal insulin initiators with CVD vs. 3431 without

Back to article page